4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-006652
Director bought 10,000 shares at $8.01 ($80,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar Director | 2022-02-02 | Purchase | +10,000 | $8.01 | $80,100 | 29,226 | D |
| Open-market purchases · 10,000 sh · avg $8.01 · $80,100 | |||||||
Loading xslF345X03/doc4.xml…